Immediate impact | Change in trend | Absolute change in outcome a month after COVID-19 | Relative change in outcome a month after COVID-19 (%) | |||
B | 95% CI | B | 95% CI | |||
Male | ||||||
Children (≥7 yo) | −3795.81* | −5361.47 to −2230.15 | −0.36 | −179.70 to 178.99 | −3796.17 | −47.60 |
Adolescents (8–17 yo) | −2899.09* | −5673.12 to −125.05 | 122.73 | −188.30 to 433.77 | −2776.35 | −10.57 |
Adults (18–64 yo) | −168 291.27 | −439 366.75 to 102 784.21 | 27 129.40 | −3468.68 to 57 727.48 | −141 161.87 | −5.74 |
Older adults (65–74 yo) | −34 403.70 | −100 896.53 to 32 089.14 | 13 162.11* | 4929.03 to 21 395.18 | −21 241.59 | −1.58 |
Elderly (≥75 yo) | −30 939.04 | −94 317.29 to 32 439.20 | 14 582.46* | 6863.67 to 22 301.26 | −16 356.58 | −1.25 |
Female | ||||||
Children (≥7 yo) | −2938.74* | −3966.10 to −1911.38 | −26.05 | −133.60 to 81.50 | −2964.79 | −47.82 |
Adolescents (8–17 yo) | −7142.78* | −12 399.81 to −1885.75 | 521.04 | −5.99 to 1048.07 | −6621.74 | −27.46 |
Adults (18–64 yo) | −80 580.27 | −676 807.98 to 515 647.44 | 45 887.32 | −23 833.17 to 115 607.81 | −34 692.95 | −0.77 |
Older adults (65–74 yo) | −186 383.98 | −374 446.64 to 1678.67 | 40 328.93* | 17 743.87 to 62 913.98 | −146 055.06 | −4.50 |
Elderly (≥75 yo) | −330 938.28* | −516 988.89 to −144887.66 | 55 986.34* | 34 033.34 to 77 939.34 | −274 951.94 | −7.20 |
Total | −724 445.94 | −1 881 469.52 to 432 577.63 | 185 245.64* | 40 314.44 to 330 176.85 | −539 200.30 | −3.37 |
The impact of the COVID-19 pandemic on the prescription of antidepressants.
*p<0.05